All manuscripts
Publications NK Cells

Detection of response to tumor microenvironment–targeted cellular immunotherapy using nano-radiomics

Published Journal Science Advances

Share
11 pages Detection of response to tumor microenvironment–targeted cellular immunotherapy using nano-radiomics — Science Advances, 2020

Overview

This study explores nano-radiomics to assess response to MDSC-directed NK cell therapy in solid tumors. Human NK cells were activated and expanded in G-Rex® devices for in vivo testing. Radiomic analysis of CT images successfully identified treatment responses that conventional tumor metrics failed to detect.

What this paper found

Radiomic analysis of nanoparticle contrast-enhanced images detected the effect of cellular immunotherapy aimed at the tumor microenvironment, where conventional tumor measurements did not. In a mouse neuroblastoma xenograft containing human myeloid-derived suppressor cells (MDSCs), NKG2D.ζ-modified NK cells depleted intratumoral MDSCs and lowered vessel density, yet CT-derived tumor volume, attenuation and fractional blood volume did not differ between groups. Of 107 radiomic features, 91 were tested; 10 features from delayed CT, 13 from CT angiography and 5 from T2-weighted MRI separated treated from untreated tumors, mainly GLSZM and GLRLM texture features. The work is preclinical.

Note: Preclinical mouse xenograft study; the authors note that the predictive power of radiomic features for tumor response has not been evaluated and that scan-parameter effects need further investigation.

Our study shows that TME-directed cellular immunotherapy causes subtle changes not effectively gauged by conventional imaging metrics but revealed by nano-radiomics. — Laxman Devkota, Zbigniew Starosolski, Charlotte H. Rivas, Igor Stupin, Ananth Annapragada, Ketan B. Ghaghada, Robin Parihar, Science Advances

Study details

Authors
Laxman Devkota, Zbigniew Starosolski, Charlotte H. Rivas, Igor Stupin, Ananth Annapragada, Ketan B. Ghaghada, Robin Parihar
Institution
Singleton Department of Pediatric Radiology, Texas Children's Hospital, Houston, TX, USA · Department of Pediatrics, Section of Hematology-Oncology, Baylor College of Medicine, Houston, TX, USA · Department of Radiology, Baylor College of Medicine, Houston, TX, USA · Center for Cell and Gene Therapy, Texas Children's Hospital, Houston Methodist Hospital, and Baylor College of Medicine, Houston, TX, USA
Journal
Science Advances
Year
2020
PMID / PMC
PMID: 32832602 · PMC
Cell type(s)
NK Cells
Application area
Solid tumor
Study phase
Preclinical

How G-Rex® was used

G-Rex® cell culture devices were used to expand and activate human NK cells before gene modification. Healthy-donor PBMCs were cocultured with irradiated K562-mb15-41BB-L feeder cells at a 1:10 NK cell to irradiated tumor cell ratio for 4 days in Stem Cell Growth Medium with 10% FBS and IL-2 at 500 IU/ml. After retroviral transduction, cells were expanded again in G-Rex® devices at the same ratio with IL-2 at 100 IU/ml. The 17-day protocol gave a more than 95% pure CD56+/CD3- NK population, with an average of 72.1% of NK cells transduced.

Note: The expanded NKG2D.ζ NK cells were the TME-directed therapy infused into the xenograft mice.

Explore related

Full citation

Devkota L, Starosolski Z, Rivas CH, et al. Detection of response to tumor microenvironment–targeted cellular immunotherapy using nano-radiomics. Sci Adv. 2020;6(28):eaba6156.

Building a similar workflow?

Talk to a ScaleReady specialist about how the G-Rex® platform can support your program — from process development to clinical-scale manufacturing.

Start a conversation →